eSOMA-DM1, a Maytansinoid-Based Theranostic Small-Molecule Drug Conjugate for Neuroendocrine Tumors.

Autor: Chapeau D; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, the Netherlands.; Erasmus MC Cancer Institute, Rotterdam 3015 GD, the Netherlands., Beekman S; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, the Netherlands.; Erasmus MC Cancer Institute, Rotterdam 3015 GD, the Netherlands., Piet A; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, the Netherlands.; Erasmus MC Cancer Institute, Rotterdam 3015 GD, the Netherlands., Li L; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, the Netherlands.; Erasmus MC Cancer Institute, Rotterdam 3015 GD, the Netherlands., de Ridder C; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, the Netherlands.; Erasmus MC Cancer Institute, Rotterdam 3015 GD, the Netherlands., Stuurman D; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, the Netherlands.; Erasmus MC Cancer Institute, Rotterdam 3015 GD, the Netherlands., Seimbille Y; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam 3015 GD, the Netherlands.; Erasmus MC Cancer Institute, Rotterdam 3015 GD, the Netherlands.

Publikováno v: Bioconjugate chemistry [Bioconjug Chem] 2024 Nov 20; Vol. 35 (11), pp. 1823-1834. Date of Electronic Publication: 2024 Oct 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.

Autor: Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Van Hemelryk A; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., de Ridder C; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Stuurman D; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Erkens-Schulze S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van 't Geloof S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Teubel WJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, The Netherlands., Martens-Uzunova ES; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van Royen ME; Department of Pathology, Erasmus University Medical Center Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van Weerden WM; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 May 02; Vol. 23 (5), pp. 711-720.

PB0317 Novel Luminescent-Based ADAMTS13 Activity Assay

Autor: Steeghs, D., Merx, J., van Geffen, M., Van de Ridder, C., van den Bosch, M., Boltje, T., Van‘t veer, C., van Heerde, W.

Publikováno v: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2

Determining the ideal mass and clinical potential of a bimodal probe for image-guided surgery of GRPR-positive cancer

Autor: Verhoeven, M., Handula, M., Van den Brink, L., De Ridder, C. M. A., Stuurman, D. C., Seimbille, Y., Dalm, S. U.

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging, 49(SUPPL 1):OP-034, S16-S16. Springer-Verlag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::b709a33f61c80a20aa2c85541df45ac4
https://pure.eur.nl/en/publications/cfd71ad7-e2fd-476a-9c78-8d3f5413899a